Zimmer Biomet Holdings (ZBH) Divestments (2021 - 2022)
Zimmer Biomet Holdings' (ZBH) quarterly Divestments came in at -$7.2 million in Q1 2022, up 49.3% year-on-year from -$4.8 million in Q1 2021, and up 67.57% quarter-over-quarter from -$22.2 million in Q4 2021.
Zimmer Biomet Holdings (ZBH) Divestments (2021 - 2022) Analysis & Trends
Zimmer Biomet Holdings' Divestments history runs 2 years deep, the most recent figure standing at -$7.2 million for Q1 2022.
- On a quarterly basis, Divestments rose 49.3% year-over-year to -$7.2 million in Q1 2022; TTM through Dec 2022 was -$7.2 million, a 88.06% increase from a year earlier, with the FY2022 full-year figure at -$7.2 million, up 88.06% from the prior year.
- Divestments rose to -$7.2 million in Q1 2022 per ZBH's latest filing, from -$22.2 million in the prior quarter.
- Across five years, Divestments topped out at -$7.2 million in Q1 2022 and bottomed at -$22.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.37 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -7.20 Mn |
| Dec 31, 2021 | -22.20 Mn |
| Sep 30, 2021 | -12.90 Mn |
| Jun 30, 2021 | -11.00 Mn |
| Mar 31, 2021 | -14.20 Mn |